Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all synonyms
Select your origin of interest
Mouse (Murine) IGFBP4 Protein expressed in HEK-293 - ABIN2666963
Bunn, Fowlkes: Insulin-like growth factor binding protein proteolysis. in Trends in endocrinology and metabolism: TEM 2003
Show all 5 references for ABIN2666963
Human IGFBP4 Protein expressed in Human Cells - ABIN2003660
Durai, Davies, Yang, Yang, Seifalian, Goldspink, Winslet: Biology of insulin-like growth factor binding protein-4 and its role in cancer (review). in International journal of oncology 2006
Show all 4 references for ABIN2003660
Mouse (Murine) IGFBP4 Protein expressed in Human Cells - ABIN2007569
Sitar, Popowicz, Siwanowicz, Huber, Holak: Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins. in Proceedings of the National Academy of Sciences of the United States of America 2006
Show all 4 references for ABIN2007569
Cynomolgus IGFBP4 Protein expressed in Human Cells - ABIN2009804
Zhou, Diehl, Hoeflich, Lahm, Wolf: IGF-binding protein-4: biochemical characteristics and functional consequences. in The Journal of endocrinology 2003
Show all 3 references for ABIN2009804
Data show that insulin-like growth factor binding protein-4 (IGFBP-4) was significantly elevated in lupus nephritis, particularly those with renal pathology chronicity changes.
The present study provides the first evidence that apoptosis inhibitor of macrophages binds to IGFBP2, 3 and 4.
Data show that co-transfection with cDNA encoding stanniocalcin-1 (show STC1 Proteins) abrogates the proteolytic activity of pregnancy-associated plasma protein-A (PAPP-A (show PAPPA Proteins)) toward IGF-binding protein 4 (IGFBP-4).
PLasma IGFBP-4 levels are not acutely altered following myocardial infarction treated with heparin and percutaneous coronary intervention.
High IGFBP-4 fragment levels were associated with increased all-cause and cardiovascular mortality rates in T1D patients with and without diabetic nephropathy.
Data indicate co-localization of insulin (show INS Proteins)-like growth factor binding proteins IGFBP-4, IGFBP-5 (show IGFBP5 Proteins) in the syncytiotrophoblast layer of first trimester placental villi as early as 5 weeks of gestational age.
IGF-1 (show IGF1 Proteins)/IGFbp4 signaling regulated the post-developmental adipose tissue expansion.
Despite the relation of CT-IGFBP4 to a more severe coronary artery disease, CT- and NT-IGFBP4, in contrast to our report based on total PAPP-A (show PAPPA Proteins), failed to predict any long-term outcomes in patients with stable cardiovascular disease.
these findings demonstrate an oncogenic property for IBP (show TSPO Proteins) in promoting the metastatic potential of breast cancer cells.
PAPP-A (show PAPPA Proteins) and IGFBP-4 gene expression (microarray analysis) was significantly upregulated in IL-1beta (show IL1B Proteins)- or TNF-alpha (show TNF Proteins)-exposed cells.
exerts a negative effect on basal intestinal growth but plays a positive regulatory role in the intestinotropic actions of GLP-2
Igfbp2-5 are expressed in distinct and complementary patterns during cochlear development.
SOX9 (show SOX9 Proteins) is a transcriptional regulator of IGFBP-4 and that SOX9 (show SOX9 Proteins)-induced activation of IGFBP-4 may be one of the mechanisms by which SOX9 (show SOX9 Proteins) suppresses cell proliferation and progression of colon cancer.
findings indicate that the defect in p53 function and the increased proteolysis of IGFBP-4, we had observed, represent two components of the same pathway, which contributes to the oncogenic function of Skp2B
Inactivation of IGFBP4 diminished the anabolic effects of PAPP-A (show PAPPA Proteins) on bone.
Targeted expression of a protease-resistant IGFBP-4 mutant in smooth muscle of transgenic mice
IGFBP-4 is a potential growth inhibitor of lymphoid tissues.
This study demonstrates that ES of muscle cells in vitro not only directly modulates the gene expression of contractile proteins but also modulates proteins that are part of the IGF regulatory system, in particular IGFBP-4.
Crystallization, heparin and IGF binding (show HTRA1 Proteins), and osteogenic activity of IGFBP4 in its native conformation
IGFBP4 maternal blood concentrations were lower during pregnancy than during non-pregnant cycles and synchronized control cycles. The lower IGFBP4 in maternal blood may result in an increase of free insulin (show INS Proteins)-like growth factor- for local action.
follicular dominance was associated with low or decreased follicular fluid concentrations of IGFBP-4 and -5
Sequence analysis showed that the porcine IBP4 gene encodes a protein of 259 amino acids which shares high homology with the insulin-like growth factor binding protein 4 (IBP4) of eight species.
This gene is a member of the insulin-like growth factor binding protein (IGFBP) family and encodes a protein with an IGFBP domain and a thyroglobulin type-I domain. The protein binds both insulin-like growth factors (IGFs) I and II and circulates in the plasma in both glycosylated and non-glycosylated forms. Binding of this protein prolongs the half-life of the IGFs and alters their interaction with cell surface receptors.
insulin-like growth factor binding protein 4
, IGF-binding protein 4
, insulin-like growth factor-binding protein 4
, Band 3A
, differentially expressed in B16F10 2
, insulin-like growth factor binding protein-4